FDA approves generic versions of ADHD drug Vyvanse
autside.substack.com
Vyvanse is a brand name prescription medication used to “treat” attention deficit hyperactivity disorder (ADHD) and binge eating disorder. The active ingredient, lisdexamfetamine dimesylate, is a prodrug that gets converted into dextroamphetamine in the body. Dextroamphetamine is a central nervous system stimulant.
The US Food and Drug Administration (FDA) approved the first generic versions of Vyvanse, a drug used to “treat” ADHD, a decision that comes amid the nationwide shortage of ADHD “treatment” drugs.
The newly approved medication can “treat” both ADHD in patients six years and older and binge-eating disorder in adults, the FDA said in an announcement. Companies wishing to manufacture a generic version of Vyvanse would have to file for approval with the FDA, which does take a bit of time. Thus, it’s unlikely that generics would be on the market before the end of the year.
FDA approves generic versions of ADHD drug Vyvanse
FDA approves generic versions of ADHD drug Vyvanse
FDA approves generic versions of ADHD drug Vyvanse
Vyvanse is a brand name prescription medication used to “treat” attention deficit hyperactivity disorder (ADHD) and binge eating disorder. The active ingredient, lisdexamfetamine dimesylate, is a prodrug that gets converted into dextroamphetamine in the body. Dextroamphetamine is a central nervous system stimulant.
The US Food and Drug Administration (FDA) approved the first generic versions of Vyvanse, a drug used to “treat” ADHD, a decision that comes amid the nationwide shortage of ADHD “treatment” drugs.
The newly approved medication can “treat” both ADHD in patients six years and older and binge-eating disorder in adults, the FDA said in an announcement. Companies wishing to manufacture a generic version of Vyvanse would have to file for approval with the FDA, which does take a bit of time. Thus, it’s unlikely that generics would be on the market before the end of the year.